RDGL VIVOS INC

RDGL financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1449349 Exchange: OTC SIC: 3841 (Surgical & Medical Instruments & Apparatus) Latest filing: 10-Q filed Nov 12, 2026 Data checked: Nov 13, 2026
Showing 3 of 16 annual and 0 of 63 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$47.71M (Jun 2025)
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Incorporated
DE
Fiscal Year End
December (1231)
Phone
509-736-4000
EIN
800138937
Headquarters
RICHLAND, WA, 99352
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: ADVANCED MEDICAL ISOTOPE Corp (2008–2017)

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$126.12K
Net Income
$-3.83M
Total Assets
$2.28M
Total Equity
$2.06M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
6.8%
Operating Margin
-2414%
Net Margin
-3032.9%
Return on Equity
-185.4%
Return on Assets
-167.5%
Current Ratio
12.33x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, VIVOS INC recorded $68.38K of revenue, net loss of $3.07M, and an operating cash outflow of $2.06M. At $68.38K, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 144.3% above fiscal 2024 revenue of $28.00K, marking a year-over-year increase. The company reported diluted EPS of -$0.01, adding a shareholder-level measure to the absolute income figures considered below. A diluted share base of 452.72M links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. Diluted shares moved 10.5% from 409.67M in fiscal 2024, leaving the current share base higher year over year. Total assets stood at $1.87M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. The revenue-to-assets relationship was 0.04x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

Direct costs exceeded revenue, producing a gross loss of $59.76K before operating expenses. Gross margin was -87.4%, reflecting direct costs that exceeded revenue by 87.4%. The reported operating result was an operating loss of $3.17M, reflecting costs that exceeded gross profit. After all below-operating-line items, the company recorded a net loss of $3.07M for the fiscal year. Negative EBITDA totaled $3.16M, confirming that the earnings deficit remained before depreciation and amortization. Before income taxes, the company recorded a loss of $3.07M, bridging the operating result to the final net loss. The loss-to-equity relationship was 184.6%, placing the bottom-line deficit against shareholder capital. The loss-to-assets relationship was 164.2%, placing the bottom-line deficit against the company’s resource base. The bottom-line deficit increased from $2.91M in fiscal 2024 to $3.07M.

Liquidity and Capital Structure

Total assets were $1.87M, supported by $206.74K of liabilities and $1.66M of shareholder equity. The near-term balance sheet paired $1.65M of current assets with $117.89K of current liabilities at the reporting date. The current ratio was 14.0x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Equity equaled 88.9% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 11.1%, placing reported obligations against the full positive asset balance. Total assets were 16.4% lower than fiscal 2024 assets of $2.23M, measuring the company’s own balance-sheet change. Book equity was 22.7% lower than fiscal 2024 equity of $2.15M, showing how shareholder capital changed year over year.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $2.06M, showing that operations absorbed cash during the period. The company spent $103.19K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Operating cash flow and capital spending combined to leave a $2.16M cash deficit after capital spending. The free-cash-flow deficit equaled 115.7% of total assets, placing the cash shortfall against the company’s resource base. Compared with a $1.68M operating cash outflow in fiscal 2024, the current outflow increased to $2.06M.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for VIVOS INC
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $68.38K $28.00K $19.50K
Cost of Revenue $128.13K $30.98K $25.54K
Gross Profit $-59.76K $-2.98K $-6.04K
OPERATING EXPENSES
R&D Expense $352.23K $324.63K $732.70K
SG&A Expense $296.56K $241.82K $165.77K
Other Operating Expenses (derived) $2.46M $2.03M $1.89M
Operating Income $-3.17M $-2.60M $-2.79M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $99.03K $-306.06K $-101.61K
Pretax Income $-3.07M $-2.91M $-2.89M
Net Income $-3.07M $-2.91M $-2.89M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.01 $-0.01 $-0.01
Diluted Shares 452.72M 409.67M 368.81M
EBITDA $-3.16M - -
Depreciation & Amortization $374 - -
Balance Sheet
ASSETS
Cash & Equivalents - $2.21M $1.59M
Accounts Receivable $22.33K $10.33K $7.00K
Inventory $57.26K - -
Other Current Assets $12.96K $10.58K $10.84K
Current Assets $1.65M $2.23M $1.61M
PP&E (Net) $102.81K - -
Other Noncurrent Assets $3.00K - -
Noncurrent Assets $216.51K $0 $0
Total Assets $1.87M $2.23M $1.61M
LIABILITIES
Accounts Payable $92.47K $86.21K $245.00K
Current Liabilities $117.89K $86.21K $245.00K
Noncurrent Liabilities $88.85K $0 $0
Total Liabilities $206.74K $86.21K $245.00K
EQUITY
Common Stock $455.49K $440.87K $387.89K
Additional Paid-in Capital $80.28M $77.72M $73.79M
Retained Earnings $-88.43M $-85.36M $-82.45M
Total Equity $1.66M $2.15M $1.37M
Total Liabilities & Equity $1.87M $2.23M $1.61M
SUPPLEMENTAL
Shares Outstanding 455.49M 440.87M 387.89M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-2.06M $-1.68M $-1.29M
Capital Expenditures $103.19K - -
Cash from Investing $-103.19K $0 $0
Cash from Financing $1.51M $2.30M $1.18M
Free Cash Flow $-2.16M - -
Beginning Cash (CFS) $2.21M $1.59M $1.71M
Net Change in Cash $-654.02K $620.26K $-113.78K
Effect of FX on Cash - - -
Calculated Ending Cash $1.56M $2.21M $1.59M
Cash per BS - $2.21M $1.59M
Cash scope difference (CFS − BS) - - -
Cash per CFS $1.56M $2.21M $1.59M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is VIVOS INC's annual revenue?

VIVOS INC reported $126.12K in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is VIVOS INC profitable?

No. VIVOS INC reported $-3.83M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.